Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.618 CHF
286.70 M CHF
3.59 B CHF
344.49 M
About NOVONESIS (NOVOZYMES A/S) B
Sector
Industry
CEO
Ester Baiget
Website
Headquarters
Lyngby
ISIN
DK0060336014
FIGI
BBG006TLSNM3
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of NZM2 is 61.437 CHF — it has increased by 20.57% in the past 24 hours. Watch NOVONESIS B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange NOVONESIS B stocks are traded under the ticker NZM2.
NZM2 stock has risen by 19.36% compared to the previous week, the month change is a 19.36% rise, over the last year NOVONESIS B has showed a 7.87% increase.
We've gathered analysts' opinions on NOVONESIS B future price: according to them, NZM2 price has a max estimate of 73.07 CHF and a min estimate of 49.26 CHF. Watch NZM2 chart and read a more detailed NOVONESIS B stock forecast: see what analysts think of NOVONESIS B and suggest that you do with its stocks.
NZM2 reached its all-time high on Dec 17, 2021 with the price of 72.864 CHF, and its all-time low was 39.686 CHF and was reached on Oct 30, 2023. View more price dynamics on NZM2 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NZM2 stock is 17.06% volatile and has beta coefficient of 0.20. Track NOVONESIS B stock price on the chart and check out the list of the most volatile stocks — is NOVONESIS B there?
Today NOVONESIS B has the market capitalization of 28.44 B, it has decreased by −0.69% over the last week.
Yes, you can track NOVONESIS B financials in yearly and quarterly reports right on TradingView.
NOVONESIS B is going to release the next earnings report on Aug 21, 2025. Keep track of upcoming events with our Earnings Calendar.
NZM2 earnings for the last quarter are 0.40 CHF per share, whereas the estimation was 0.38 CHF resulting in a 6.16% surprise. The estimated earnings for the next quarter are 0.62 CHF per share. See more details about NOVONESIS B earnings.
NOVONESIS B revenue for the last quarter amounts to 1.03 B CHF, despite the estimated figure of 1.02 B CHF. In the next quarter, revenue is expected to reach 972.81 M CHF.
NZM2 net income for the last quarter is 177.98 M CHF, while the quarter before that showed 86.99 M CHF of net income which accounts for 104.60% change. Track more NOVONESIS B financial stats to get the full picture.
NOVONESIS B dividend yield was 1.52% in 2024, and payout ratio reached 124.39%. The year before the numbers were 1.67% and 56.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 14, 2025, the company has 10.58 K employees. See our rating of the largest employees — is NOVONESIS B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVONESIS B EBITDA is 1.11 B CHF, and current EBITDA margin is 30.77%. See more stats in NOVONESIS B financial statements.
Like other stocks, NZM2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVONESIS B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVONESIS B technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVONESIS B stock shows the buy signal. See more of NOVONESIS B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.